07.07.10
International Chemical Investors Group (ICIG) has realigned its pharma unit, Corden Pharma Group, following the acquisition of its fifth manufacturing facility. The new site, in Sermoneta, Italy, will be known as Corden Pharma Latina SpA. Other units in the pharma group are
ICIG has named Wolfgang Niedermaier as president of Corden Pharma Group as of July 1st 2010. In this new role he will give strategic guidance to the group companies. He will also be responsible for sales and marketing as well as corporate development of the group.
Corden Pharma Group has more than 1,000 employees and, according to a company statement, "is striving to become a leader in contract development of APIs for generics as well as for exclusive products (new chemical formulations), contract manufacturing for high potent substances, sterile substances and selected preparations for parenteral application."
- Corden Pharma SpA, in Caponago, Italy,
- Corden Pharma GmbH, in Plankstadt, Germany,
- Synkem SAS, in Chenove, France, and
- Corden Pharma, an R&D facility in Cork, Ireland.
ICIG has named Wolfgang Niedermaier as president of Corden Pharma Group as of July 1st 2010. In this new role he will give strategic guidance to the group companies. He will also be responsible for sales and marketing as well as corporate development of the group.
Corden Pharma Group has more than 1,000 employees and, according to a company statement, "is striving to become a leader in contract development of APIs for generics as well as for exclusive products (new chemical formulations), contract manufacturing for high potent substances, sterile substances and selected preparations for parenteral application."